Zurcher Kantonalbank (Zurich Cantonalbank) Chemo Centryx, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$15.36 - $27.51 $1,351 - $2,420	-88 Reduced 1.11%	7,831 $194,000
Q1 2022 Apr 21, 2022	SELL	$22.22 - $39.12 $35,885 - $63,178	-1,615 Reduced 16.94%	7,919 $199,000
Q4 2021 Feb 01, 2022	BUY	$18.38 - $40.5 $68,630 - $151,227	3,734 Added 64.38%	9,534 $347,000
Q1 2021 May 03, 2021	SELL	$49.53 - $68.4 $37,642 - $51,984	-760 Reduced 11.59%	5,800 $297,000
Q4 2020 Jan 28, 2021	BUY	$47.25 - $65.16 $102,154 - $140,875	2,162 Added 49.16%	6,560 $406,000
Q2 2020 Jul 28, 2020	BUY	$38.58 - $65.07 $69,906 - $117,906	1,812 Added 70.07%	4,398 $253,000
Q4 2019 Jan 21, 2020	BUY	$6.81 - $39.55 $9,990 - $58,019	1,467 Added 131.1%	2,586 $102,000
Q2 2019 Jul 30, 2019	BUY	$8.31 - $14.85 $9,298 - $16,617	1,119 New	1,119 $10,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account